|Title||Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways.|
|Publication Type||Journal Article|
|Year of Publication||2011|
|Authors||Palmieri, M, Impey, S, Kang, H, di Ronza, A, Pelz, C, Sardiello, M, Ballabio, A|
|Journal||Hum Mol Genet|
|Date Published||2011 Oct 01|
|Keywords||Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Gene Expression Regulation, Gene Regulatory Networks, HeLa Cells, Humans, Lysosomes, Promoter Regions, Genetic, Protein Binding, Proteins|
In metazoans, lysosomes are the center for the degradation of macromolecules and play a key role in a variety of cellular processes, such as autophagy, exocytosis and membrane repair. Defects of lysosomal pathways are associated with lysosomal storage disorders and with several late onset neurodegenerative diseases. We recently discovered the CLEAR (Coordinated Lysosomal Expression and Regulation) gene network and its master gene transcription factor EB (TFEB), which regulates lysosomal biogenesis and function. Here, we used a combination of genomic approaches, including ChIP-seq (sequencing of chromatin immunoprecipitate) analysis, profiling of TFEB-mediated transcriptional induction, genome-wide mapping of TFEB target sites and recursive expression meta-analysis of TFEB targets, to identify 471 TFEB direct targets that represent essential components of the CLEAR network. This analysis revealed a comprehensive system regulating the expression, import and activity of lysosomal enzymes that control the degradation of proteins, glycosaminoglycans, sphingolipids and glycogen. Interestingly, the CLEAR network appears to be involved in the regulation of additional lysosome-associated processes, including autophagy, exo- and endocytosis, phagocytosis and immune response. Furthermore, non-lysosomal enzymes involved in the degradation of essential proteins such as hemoglobin and chitin are also part of the CLEAR network. Finally, we identified nine novel lysosomal proteins by using the CLEAR network as a tool for prioritizing candidates. This study provides potential therapeutic targets to modulate cellular clearance in a variety of disease conditions.
|Alternate Journal||Hum Mol Genet|
|Grant List||250154 / ERC_ / European Research Council / International |
TGM11CB6 / TI_ / Telethon / Italy
Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways.
|Single-cell multiomics of the human retina reveals hierarchical transcription factor collaboration in mediating cell type-specific effects of genetic variants on gene regulation. Genome Biol. 2023;24(1):269..|
|PLS3 missense variants affecting the actin-binding domains cause X-linked congenital diaphragmatic hernia and body-wall defects. Am J Hum Genet. 2023;110(10):1787-1803..|
|Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer. Front Immunol. 2023;14:1188831..|